483
Virginia Center for Reproductive MedicineVirginia Center for Reproductive Medicine – FDA 483, Oct 29, 2021
Record Details
The FDA inspected Virginia Center for Reproductive Medicine in Reston, VA, and found significant issues with donor screening and product labeling. The firm failed to adequately screen HCT/P donors for communicable disease risk factors, including Zika virus, and used deficient medical history interview forms. Additionally, HCT/Ps from ineligible donors with reactive tests for syphilis and Hepatitis B were not properly labeled with required warning statements.
- Inspection date
- October 29, 2021
- Product type
- biologics
View Company Profile
ID · 025348e0-e7bf-4346-9515-19990614692b
Other documents for Virginia Center for Reproductive Medicine
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.